You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 114 No. 10, October 1978 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Letters to the Editor
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Autoimmunity and Vitiligo

Phaedon Harsoulis, MD; Florence Kanakoudi-Tsakalidis, MD; Athanasios Vyzantiadis, MD; Aristipos Minas, MD; Christos Cassimos, MD
Thessaloniki, Greece

Arch Dermatol. 1978;114(10):1554.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The autoimmune nature of vitiligo, at least for a certain number of patients, seems to be more and more likely. Previous reports of an increased incidence of organspecific autoantibodies in those patients support this concept.1-4 The theory has been strengthened recently by the detection of a circulating antibody in two patients with vitiligo, alopecia totalis, mucocutaneous candidiasis, and multiple endocrine insufficiencies, using an immunofluorescent complement-fixation test. This antibody was found bound to melanocytes in human skin, nevus cells, and melanoma cells.5

We here report our results of a study that aimed to demonstrate the presence of certain organ-specific autoantibodies in patients with vitiligo and the association of this disorder with autoimmune diseases.

Patients and Methods.—

Eighty-five patients (aged 4 to 78 years) with generalized or localized vitiligo were studied during a period of three years. The patients included in this study were selected on the . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.